(Q63446346)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

1 reference

1 reference

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

21

Champlin RE

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

9

Giralt S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Donato ML

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Gershenson D

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Ippoliti C

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Wharton JT

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Bast RC Jr

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Aleman A

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Anderlini P

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Gajewski JG

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Molldrem J

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Ueno N

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Lauppe J

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Korbling M

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Boyer J

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Bevers M

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Burke T

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Freedman R

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Levenback C

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Wolf J

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1137-1140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10849525%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702421

7 November 2019

exact match

0 references

cites work

High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702421

7 January 2021

High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702421

7 January 2021

Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702421

7 January 2021

Combined chemotherapy and granulocyte colony-stimulating factor (G-CSF) mobilise large numbers of peripheral blood progenitor cells in pretreated patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702421

7 January 2021

A study of ovarian cancer patients treated with dose-intensive chemotherapy supported with peripheral blood progenitor cells mobilised by filgrastim and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702421

7 January 2021

Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702421

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702421

7 January 2021

Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702421

7 January 2021

Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702421

7 January 2021

A phase 2 trial of ifosfamide/mesna as salvage therapy in patients with ovarian cancer refractory to or relapsing after prior platinum-containing chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702421

7 January 2021

Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702421

7 January 2021

Effect of the exposure dose of etoposide on the cell growth and cell kinetics of human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702421

7 January 2021

Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702421

7 January 2021

Phase II evaluation of VP-16-213 (NSC-141540) in patients with advanced ovarian carcinoma resistant to alkylating agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702421

7 January 2021

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702421

7 January 2021

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702421

7 January 2021